The largest holder of Colgate-Palmolive stock is Vanguard Capital Management LLC, with 52.2 million shares (6.55% of the company), worth about $4.69 billion as of September 25, 2026. The 10 largest holders together own 36.4%.
In Q2 2026, 2,101 institutional holdings reports listed 788.0 million shares worth $68.90 billion, up 16.6% in shares from Q1 2026.
Insiders reported 85 transactions in the last two years: 16 sales worth $40.93 million and no purchases. The newest one on file is from May 11, 2026 (Newman Brian, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 11, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Vanguard Capital Management LLC | 52.2 million | 6.55% | $4.7B |
| BlackRock Advisors LLC | 49.9 million | 6.26% | $4.5B |
| State Street Corporation | 47.0 million | 5.90% | $4.2B |
| T. Rowe Price International Ltd. | 27.9 million | 3.50% | $2.5B |
| Vanguard Portfolio Management LLC | 24.0 million | 3.01% | $2.2B |
| Geode Capital Management LLC | 23.1 million | 2.90% | $2.1B |
| Eaton Vance Management | 22.1 million | 2.77% | $2.0B |
| BlackRock Life Ltd. | 18.4 million | 2.31% | $1.7B |
| BNY Mellon Investment Adviser, Inc. | 13.5 million | 1.70% | $1.2B |
| DWS Investment Management Americas, Inc. | 11.8 million | 1.47% | $1.1B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 2,101 | 788.0 million | $68.9B |
| Q1 2026 | 2,040 | 676.0 million | $57.4B |
| Q4 2025 | 1,964 | 675.0 million | $53.3B |
| Q3 2025 | 1,929 | 673.0 million | $53.8B |
| Q2 2025 | 2,003 | 685.0 million | $62.2B |
| Q1 2025 | 2,033 | 684.0 million | $64.1B |
| Q4 2024 | 2,024 | 688.0 million | $62.5B |
| Q3 2024 | 2,012 | 683.0 million | $70.7B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Newman Brian | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Edwards Lisa Marie | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Nelson Kimberly A. | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Boerner Christopher S | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Harris C. Martin M.D. | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Norrington Lorrie M | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Bilbrey John P. | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Hund-Mejean Martina | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Cahill John T | May 11, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Massey Sally | May 7, 2026 | Officer | Sale at price 87.41 per share. | $751,633 |
| Newman Brian | Apr 1, 2026 | Director | Stock Award(Grant) at price 89.05 per share. | $18,700 |
| Bilbrey John P. | Apr 1, 2026 | Director | Stock Award(Grant) at price 89.05 per share. | $23,687 |
Newest 12 of 85 insider transactions in the last two years.
Vanguard Capital Management LLC, with 6.55% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.26%) and State Street Corporation (5.90%).
2,101 institutional holdings reports listed Colgate-Palmolive shares in Q2 2026, 788.0 million shares in all worth $68.90 billion.
In the last two years insiders reported 16 sales and no purchases (85 transactions in all); the newest on file is from May 11, 2026.